NASDAQ : BLFS Q4 & FY2019 Earnings Call March 11, 2020 BioLife Solutions Q4 & FY2019 Earnings Call : March 11, 2020 1 Disclaimer NASDAQ: BLFS Cautions Regarding Forward Looking Statements Except for historical information contained herein, this press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements concerning the expected financial performance of the company fol ...

NASDAQ : BLFS Investor Presentation March 2020 BioLife Solutions Investor Presentation : March 2020 1 Disclaimer NASDAQ: BLFS Cautions Regarding Forward Looking Statements Except for historical information contained herein, this press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements concerning the expected financial performance of the company following the compl ...

BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2019 Earnings Conference Call March 11, 2020 5:00 PM ET Company Participants Mike Rice – President and Chief Executive Officer Roderick de Greef – Chief Financial Officer Conference Call Participants Paul Knight – Janney Montgomery Suraj Kalia – Oppenheimer and Company Jacob Johnson – Stephens Thomas Flaten – Lake Street Capital Markets Edward Marks – H.C. Wainwright Marc Wiesenberger – B. Riley FBR Operator Ladies and gentlemen, thank you for standing-by and welcome ...

BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2019 Earnings Conference Call November 12, 2019 4:30 PM ET Company Participants Roderick de Greef - CFO Mike Rice - President and CEO Conference Call Participants Paul Knight - Janney Faizzan Ahmad - H.C. Wainwright William March - Spring City Partners Operator Good afternoon ladies and gentlemen and welcome to the Q3 2019 BioLife Solutions Incorporated Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a questi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36362 BioLife Solutions, Inc. (Exact name of registrant as specified in its charter) DELAWARE 94-3076866 (State or other j ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36362 BioLife Solutions, Inc. (Exact name of registrant as specified in its charter) DELAWARE 94-3076866 (State or other jurisd ...

BioLife Solutions, Inc. (NASDAQ:BLFS) Q2 2019 Earnings Conference Call August 8, 2019 4:30 PM ET Company Participants Roderick de Greef - Chief Financial Officer Mike Rice - President & Chief Executive Officer Conference Call Participants George Zavoico - B. Riley FBR Operator Good day, ladies and gentlemen, and welcome to the BioLife Solutions Second Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and inst ...

Table of Contents ——————— UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36362 | --- | --- | |---------------------------------------------------------------------------------------|--------- ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36362 | --- | --- | |----------------------------------------------------------------------------|----------------------------- ...

BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2018 Earnings Conference Call March 14, 2019 4:30 PM ET Company Participants Roderick de Greef - Chief Financial Officer Michael Rice - President and Chief Executive Officer Conference Call Participants Paul Knight - Janney Jason McCarthy - Maxim Group Operator Good day, ladies and gentlemen. And welcome to the BioLife Solutions Fourth Quarter and Full Year 2018 Conference Call. At this time, all participants are in a listen only mode. Later, we will conduct the ques ...